Red Teaming: What Pharma Can Learn From The US Military
How the pharmaceutical industry can use a novel US military technique to hone critical decision making strategies and to underpin M&A target screening.
You may also be interested in...
In a new monthly column, Scrip rounds up events on the stock market, noting trends and exceptional performance both good and bad. This month, the focus is on 30 biopharma companies with market caps above $10bn. Between them, these 30 companies account for approximately 75% of the asset value in the pharmaceutical industry.
Although signs suggest the Trump Administration is moving back to the establishment center, biopharma’s knowledge elites remain in the populists’ crosshairs. It’s vital to change the narrative on medicines and markets. In this brief opinion piece In Vivo provides seven ways for the C-suite to do just that.
After six years as CFO of Algeta and two years as CFO and CEO of Targovax, Øystein Soug has learnt some things along the way, good and bad. Here are nine of his leadership lessons to date.